National Survey on Hypertension

Describe the clinical characteristics of hypertensive patients aged of 75 years and older seen in general practitioner consultation according to their renal damage

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Hypertension Cardiovascular Diseases Vascular Diseases

Age range

75 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Research Site, Abbeville, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Male or female aged 75 years or older
With a diagnosis of Hypertension treated or not, seen in general practitioner consultation
Who has given his/her consent to participate to the study.

Exclusion criteria

Patient who participated to a clinical trial

Treatment and study plan

Primary outcomes

Describe the clinical characteristics of hypertensive patients aged of 75 years and older seen in general practitioner consultation according to their renal damage

Time frame: once

Sponsors and collaborators

Lead sponsor

AstraZeneca

Industry

Registry information

Official study title

Profile of Hypertensive Patients Aged of 75 Years and Older Seen in General Practitioner According to Their Renal Damage.

Acronym: SERENITE

Important dates

Study start: 2008
Study completion: 2009
First posted: Dec 8, 2008
Registry last updated: Jul 21, 2009

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed